Publications by authors named "Natalyn N Hawk"

Claim this Profile
L
LEAP-014: first-line lenvatinib + pembrolizumab + chemotherapy in advanced/metastatic esophageal squamous cell carcinoma.
Jong-Mu Sun, Antoine Adenis, Peter C Enzinger, Manish A Shah, Ken Kato, Natalyn Nicole Hawk

Future Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorectal Cancer Initial Diagnosis: Screening Colonoscopy, Diagnostic Colonoscopy, or Emergent Surgery, and Tumor Stage and Size at Initial Presentation.
Courtney C Moreno, Pardeep K Mittal, Patrick S Sullivan, Robin Rutherford, Charles A Staley, Natalyn N Hawk

Clin Colorectal Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic Features and Outcome of Young Adults With Stage IV Colorectal Cancer.
Natalyn N Hawk, Tua-Elisabeth Long, Muhammad H Imam, Blessy M Mathew, Sungjin Kim

Am J Clin Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small cell carcinoma of the anus in the setting of prior squamous dysplasia and carcinoma in situ.
David M Marcus, Mark A Edgar, Natalyn N Hawk, Patrick S Sullivan, Liza J Stapleford

J Gastrointest Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR inhibition in breast cancer: unraveling the complex mechanisms of mTOR signal transduction and its clinical implications in therapy.
Ruth O'Regan, Natalyn Nicole Hawk

Expert Opin Ther Targets· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis